Stock chart
Ticker: ADVM Exchange: NMS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Total value Details
2015-05-22 2015-05-22 PS Planned sale

Schwartz Steven Daniel

Non-Executive Director
5,196 -1.3%
38.88
202,043 USD
5,196 -1.3% 38.88 202,043 USD
2015-05-22 2015-05-21 PS Planned sale

Gasmi Mehdi

VP, Pharmaceutical Development

Officer
500 -6.7%
38.87
19,435 USD
500 -6.7% 38.87 19,435 USD
2015-05-21 2015-05-19 PS Planned sale

Blumenkranz Mark S.

Non-Executive Director
1,000 -8.7%
36.91
36,911 USD
1,000 -8.7% 36.91 36,911 USD
2015-05-21 2015-05-19 PS Planned sale

Blumenkranz Mark S.

Non-Executive Director
1,000 -8.7%
36.91
36,911 USD
1,000 -8.7% 36.91 36,911 USD
2015-05-18 2015-05-15 PS Planned sale

Blumenkranz Mark S.

Non-Executive Director
4,525 -0.8%
36.00
162,886 USD
4,525 -0.8% 36.00 162,886 USD
2015-05-15 2015-05-14 PS Planned sale

Gasmi Mehdi

VP, Pharmaceutical Development

Officer
500 -6.7%
35.31
17,656 USD
500 -6.7% 35.31 17,656 USD
2015-05-13 2015-05-13 PS Planned sale

Bain Linda

Chief Financial Officer

Officer
285 -3.1%
34.94
9,959 USD
285 -3.1% 34.94 9,959 USD
2015-05-12 2015-05-11 PS Planned sale

Bain Linda

Chief Financial Officer

Officer
715 -7.4%
34.91
24,964 USD
715 -7.4% 34.91 24,964 USD
2015-05-12 2015-05-11 PS Planned sale

Wachter Paul

Non-Executive Director
132 -0.3%
34.29
4,527 USD
132 -0.3% 34.29 4,527 USD
2015-05-12 2015-05-11 PS Planned sale

Wachter Paul

Non-Executive Director
552 -1.3%
33.70
18,604 USD
552 -1.3% 33.70 18,604 USD
2015-05-08 2015-05-07 PS Planned sale

Gasmi Mehdi

VP, Pharmaceutical Development

Officer
500 -6.7%
33.28
16,638 USD
500 -6.7% 33.28 16,638 USD
2015-05-06 2015-05-04 PS Planned sale

Hull Hans

SVP, Business Operations

Officer
5,000 -30.6%
30.87
154,349 USD
5,000 -30.6% 30.87 154,349 USD
2015-05-06 2015-05-04 PS Planned sale

Bain Linda

Chief Financial Officer

Officer
2,500 -21.7%
31.59
78,972 USD
2,500 -21.7% 31.59 78,972 USD
2015-04-30 2015-04-28 PS Planned sale

Gasmi Mehdi

VP, Pharmaceutical Development

Officer
1,000 -12.5%
35.67
35,667 USD
1,000 -12.5% 35.67 35,667 USD
2015-04-23 2015-04-21 PS Planned sale

Gasmi Mehdi

VP, Pharmaceutical Development

Officer
1,000 -100.0%
39.21
39,211 USD
1,000 -100.0% 39.21 39,211 USD
2015-04-20 2015-04-16 PS Planned sale

Blumenkranz Mark S.

Non-Executive Director
200 -0.0%
42.04
8,408 USD
200 -0.0% 42.04 8,408 USD
2015-04-15 2015-04-14 PS Planned sale

Gasmi Mehdi

VP, Pharmaceutical Development

Officer
1,000 -100.0%
39.45
39,448 USD
1,000 -100.0% 39.45 39,448 USD
2015-04-15 2015-04-14 PS Planned sale

Zygtech, LLC

Major owner
4,600 -0.2%
39.93
183,663 USD
4,600 -0.2% 39.93 183,663 USD
2015-04-15 2015-04-13 PS Planned sale

Wachter Paul

Non-Executive Director
24 -0.1%
40.74
978 USD
24 -0.1% 40.74 978 USD
2015-04-15 2015-04-13 PS Planned sale

Wachter Paul

Non-Executive Director
338 -0.7%
39.85
13,468 USD
338 -0.7% 39.85 13,468 USD
2015-04-15 2015-04-13 PS Planned sale

Zygtech, LLC

Major owner
776 -0.0%
40.69
31,579 USD
776 -0.0% 40.69 31,579 USD
2015-04-15 2015-04-13 PS Planned sale

Zygtech, LLC

Major owner
7,350 -0.3%
39.94
293,587 USD
7,350 -0.3% 39.94 293,587 USD
2015-04-13 2015-04-09 PS Planned sale

Schwartz Steven Daniel

Non-Executive Director
200 -0.0%
40.38
8,076 USD
200 -0.0% 40.38 8,076 USD
2015-04-08 2015-04-08 PS Planned sale

Blumenkranz Mark S.

Non-Executive Director
2,500 -0.4%
39.94
99,841 USD
2,500 -0.4% 39.94 99,841 USD
2015-04-08 2015-04-07 PS Planned sale

Blumenkranz Mark S.

Non-Executive Director
32 -0.3%
39.06
1,250 USD
32 -0.3% 39.06 1,250 USD
2015-04-08 2015-04-07 PS Planned sale

Blumenkranz Mark S.

Non-Executive Director
968 -7.7%
38.59
37,353 USD
968 -7.7% 38.59 37,353 USD
2015-04-08 2015-04-07 PS Planned sale

Blumenkranz Mark S.

Non-Executive Director
32 -0.3%
39.06
1,250 USD
32 -0.3% 39.06 1,250 USD
2015-04-08 2015-04-07 PS Planned sale

Blumenkranz Mark S.

Non-Executive Director
968 -7.7%
38.59
37,353 USD
968 -7.7% 38.59 37,353 USD
2015-04-08 2015-04-07 PS Planned sale

Blumenkranz Mark S.

Non-Executive Director
32 -0.3%
39.06
1,250 USD
32 -0.3% 39.06 1,250 USD
2015-04-08 2015-04-07 PS Planned sale

Blumenkranz Mark S.

Non-Executive Director
968 -7.7%
38.59
37,353 USD
968 -7.7% 38.59 37,353 USD
2015-04-08 2015-04-07 PS Planned sale

Blumenkranz Mark S.

Non-Executive Director
726 -0.1%
39.06
28,358 USD
726 -0.1% 39.06 28,358 USD
2015-04-08 2015-04-07 PS Planned sale

Hull Hans

SVP, Business Operations

Officer
887 -21.1%
39.06
34,646 USD
887 -21.1% 39.06 34,646 USD
2015-04-08 2015-04-07 PS Planned sale

Hull Hans

SVP, Business Operations

Officer
26,613 -86.3%
38.59
1,026,926 USD
26,613 -86.3% 38.59 1,026,926 USD
2015-04-08 2015-04-07 PS Planned sale

Gasmi Mehdi

VP, Pharmaceutical Development

Officer
292 -100.0%
39.06
11,406 USD
292 -100.0% 39.06 11,406 USD
2015-04-08 2015-04-07 PS Planned sale

Gasmi Mehdi

VP, Pharmaceutical Development

Officer
8,708 -96.8%
38.59
336,019 USD
8,708 -96.8% 38.59 336,019 USD
2015-01-15 2015-01-13 S Sale

Blumenkranz Mark S.

Non-Executive Director
100,000 -13.4%
55.46
5,546,000 USD
100,000 -13.4% 55.46 5,546,000 USD
2015-01-15 2015-01-13 S Sale

Wachter Paul

Non-Executive Director
14,000 -22.2%
55.46
776,440 USD
14,000 -22.2% 55.46 776,440 USD
2015-01-15 2015-01-13 S Sale

Chalberg Thomas W.

Chief Executive Officer

Executive Director
85,000 -22.9%
55.46
4,714,100 USD
85,000 -22.9% 55.46 4,714,100 USD
2015-01-15 2015-01-13 S Sale

Zygtech, LLC

Major owner
100,000 -3.9%
55.46
5,546,000 USD
100,000 -3.9% 55.46 5,546,000 USD
2015-01-15 2015-01-13 S Sale

Schwartz Steven Daniel

Non-Executive Director
91,000 -16.3%
55.46
5,046,860 USD
91,000 -16.3% 55.46 5,046,860 USD
2014-08-07 2014-08-05 B Purchase

Venrock Healthcare Capital Partners II, L.P.

Major owner
400,000 +20.4%
17.00
6,800,000 USD
400,000 +20.4% 17.00 6,800,000 USD
2014-08-07 2014-08-05 B Purchase

Venrock Associates VI, L.P.

Major owner
400,000 +20.4%
17.00
6,800,000 USD
400,000 +20.4% 17.00 6,800,000 USD
2014-08-05 2014-08-05 B Purchase

REGENERON PHARMACEUTICALS INC

Major owner
588,235 +48.2%
17.00
9,999,995 USD
588,235 +48.2% 17.00 9,999,995 USD
2014-08-05 2014-08-05 B Purchase

Flynn James E

Major owner
31,650 +5.3%
24.57
777,641 USD
31,650 +5.3% 24.57 777,641 USD
2014-08-05 2014-08-05 B Purchase

Flynn James E

Major owner
49,981 +9.2%
26.35
1,316,999 USD
49,981 +9.2% 26.35 1,316,999 USD
2014-08-05 2014-08-05 B Purchase

Flynn James E

Major owner
27,600 +5.3%
26.14
721,464 USD
27,600 +5.3% 26.14 721,464 USD
2014-08-05 2014-08-05 B Purchase

Flynn James E

Major owner
12,400 +2.5%
27.54
341,496 USD
12,400 +2.5% 27.54 341,496 USD
2014-08-05 2014-08-05 B Purchase

Flynn James E

Major owner
219,864 +76.9%
26.42
5,808,807 USD
219,864 +76.9% 26.42 5,808,807 USD
2014-08-05 2014-08-05 B Purchase

Flynn James E

Major owner
18,700 +7.0%
25.79
482,273 USD
18,700 +7.0% 25.79 482,273 USD
2014-08-05 2014-08-05 B Purchase

Flynn James E

Major owner
9,800 +3.8%
25.52
250,096 USD
9,800 +3.8% 25.52 250,096 USD
2014-08-05 2014-08-05 B Purchase

Flynn James E

Major owner
201,972 +365.2%
25.41
5,132,109 USD
201,972 +365.2% 25.41 5,132,109 USD
2014-08-05 2014-08-05 B Purchase

Flynn James E

Major owner
55,300 +inf%
17.00
940,100 USD
55,300 +inf% 17.00 940,100 USD
2014-08-05 2014-08-05 B Purchase

Flynn James E

Major owner
25,600 +5.3%
24.57
628,992 USD
25,600 +5.3% 24.57 628,992 USD
2014-08-05 2014-08-05 B Purchase

Flynn James E

Major owner
40,400 +9.2%
26.35
1,064,540 USD
40,400 +9.2% 26.35 1,064,540 USD
2014-08-05 2014-08-05 B Purchase

Flynn James E

Major owner
22,400 +5.3%
26.14
585,536 USD
22,400 +5.3% 26.14 585,536 USD
2014-08-05 2014-08-05 B Purchase

Flynn James E

Major owner
10,100 +2.5%
27.54
278,154 USD
10,100 +2.5% 27.54 278,154 USD
2014-08-05 2014-08-05 B Purchase

Flynn James E

Major owner
177,700 +76.9%
26.42
4,694,834 USD
177,700 +76.9% 26.42 4,694,834 USD
2014-08-05 2014-08-05 B Purchase

Flynn James E

Major owner
15,100 +7.0%
25.79
389,429 USD
15,100 +7.0% 25.79 389,429 USD
2014-08-05 2014-08-05 B Purchase

Flynn James E

Major owner
7,900 +3.8%
25.52
201,608 USD
7,900 +3.8% 25.52 201,608 USD
2014-08-05 2014-08-05 B Purchase

Flynn James E

Major owner
163,300 +365.3%
25.41
4,149,453 USD
163,300 +365.3% 25.41 4,149,453 USD
2014-08-05 2014-08-05 B Purchase

Flynn James E

Major owner
44,700 +inf%
17.00
759,900 USD
44,700 +inf% 17.00 759,900 USD
2014-08-05 2014-08-05 B Purchase

Flynn James E

Major owner
123,077 +23.2%
17.00
2,092,309 USD
123,077 +23.2% 17.00 2,092,309 USD
2014-08-05 2014-08-05 B Purchase

Flynn James E

Major owner
34,223 +23.2%
17.00
581,791 USD
34,223 +23.2% 17.00 581,791 USD
2014-08-05 2014-08-05 B Purchase

Flynn James E

Major owner
42,700 +23.1%
17.00
725,900 USD
42,700 +23.1% 17.00 725,900 USD